|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3598122A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3993073A
(en)
|
1969-04-01 |
1976-11-23 |
Alza Corporation |
Novel drug delivery device
|
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
|
US4069307A
(en)
|
1970-10-01 |
1978-01-17 |
Alza Corporation |
Drug-delivery device comprising certain polymeric materials for controlled release of drug
|
|
US3731683A
(en)
|
1971-06-04 |
1973-05-08 |
Alza Corp |
Bandage for the controlled metering of topical drugs to the skin
|
|
US3996934A
(en)
|
1971-08-09 |
1976-12-14 |
Alza Corporation |
Medical bandage
|
|
US3742951A
(en)
|
1971-08-09 |
1973-07-03 |
Alza Corp |
Bandage for controlled release of vasodilators
|
|
BE795384A
(fr)
|
1972-02-14 |
1973-08-13 |
Ici Ltd |
Pansements
|
|
US3921636A
(en)
|
1973-01-15 |
1975-11-25 |
Alza Corp |
Novel drug delivery device
|
|
US3993072A
(en)
|
1974-08-28 |
1976-11-23 |
Alza Corporation |
Microporous drug delivery device
|
|
US4151273A
(en)
|
1974-10-31 |
1979-04-24 |
The Regents Of The University Of California |
Increasing the absorption rate of insoluble drugs
|
|
US3972995A
(en)
|
1975-04-14 |
1976-08-03 |
American Home Products Corporation |
Dosage form
|
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
|
US4031894A
(en)
|
1975-12-08 |
1977-06-28 |
Alza Corporation |
Bandage for transdermally administering scopolamine to prevent nausea
|
|
US4060084A
(en)
|
1976-09-07 |
1977-11-29 |
Alza Corporation |
Method and therapeutic system for providing chemotherapy transdermally
|
|
US4201211A
(en)
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
|
JPS5562012A
(en)
|
1978-11-06 |
1980-05-10 |
Teijin Ltd |
Slow-releasing preparation
|
|
US4230105A
(en)
|
1978-11-13 |
1980-10-28 |
Merck & Co., Inc. |
Transdermal delivery of drugs
|
|
US4229447A
(en)
|
1979-06-04 |
1980-10-21 |
American Home Products Corporation |
Intraoral methods of using benzodiazepines
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4291015A
(en)
|
1979-08-14 |
1981-09-22 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing a vasodilator
|
|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US5116817A
(en)
|
1982-12-10 |
1992-05-26 |
Syntex (U.S.A.) Inc. |
LHRH preparations for intranasal administration
|
|
US4476116A
(en)
|
1982-12-10 |
1984-10-09 |
Syntex (U.S.A.) Inc. |
Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
|
|
US4596795A
(en)
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
|
US4624848A
(en)
|
1984-05-10 |
1986-11-25 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
GB8518301D0
(en)
|
1985-07-19 |
1985-08-29 |
Fujisawa Pharmaceutical Co |
Hydrodynamically explosive systems
|
|
EP0230654B1
(en)
|
1985-12-28 |
1992-03-18 |
Sumitomo Pharmaceuticals Company, Limited |
Sustained pulsewise release pharmaceutical preparation
|
|
US4755386A
(en)
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
|
US5312325A
(en)
|
1987-05-28 |
1994-05-17 |
Drug Delivery Systems Inc |
Pulsating transdermal drug delivery system
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
IL92966A
(en)
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
US5739136A
(en)
|
1989-10-17 |
1998-04-14 |
Ellinwood, Jr.; Everett H. |
Intraoral dosing method of administering medicaments
|
|
US5017381A
(en)
|
1990-05-02 |
1991-05-21 |
Alza Corporation |
Multi-unit pulsatile delivery system
|
|
US5633009A
(en)
|
1990-11-28 |
1997-05-27 |
Sano Corporation |
Transdermal administration of azapirones
|
|
CA2108575C
(en)
|
1991-04-16 |
2002-10-22 |
Kouichi Nakamichi |
Method of manufacturing solid dispersion
|
|
ES2149781T3
(es)
|
1991-11-22 |
2000-11-16 |
Procter & Gamble Pharma |
Composiciones de risedronato de liberacion retardada.
|
|
US5229135A
(en)
|
1991-11-22 |
1993-07-20 |
Prographarm Laboratories |
Sustained release diltiazem formulation
|
|
US5340591A
(en)
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
US5260068A
(en)
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
|
US5281420A
(en)
|
1992-05-19 |
1994-01-25 |
The Procter & Gamble Company |
Solid dispersion compositions of tebufelone
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
|
US5700485A
(en)
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
|
ATE223704T1
(de)
|
1992-10-16 |
2002-09-15 |
Nippon Shinyaku Co Ltd |
Verfahren zur herstellung von wachsmatrizes
|
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US6326469B1
(en)
|
1994-04-22 |
2001-12-04 |
Sugen, Inc. |
Megakaryocytic protein tyrosine kinases
|
|
US5665378A
(en)
|
1994-09-30 |
1997-09-09 |
Davis; Roosevelt |
Transdermal therapeutic formulation
|
|
US5567441A
(en)
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
|
KR19990014865A
(ko)
|
1995-05-17 |
1999-02-25 |
피터 이. 브래이브맨 |
소장에서의 소화 및 흡수를 증진시키기 위한, 지방산을 함유한조성물들
|
|
SE9502244D0
(sv)
|
1995-06-20 |
1995-06-20 |
Bioglan Ab |
A composition and a process for the preparation thereof
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
US6923983B2
(en)
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
|
US6929801B2
(en)
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
|
US6391452B1
(en)
|
1997-07-18 |
2002-05-21 |
Bayer Corporation |
Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
|
|
ES2308821T3
(es)
|
1997-12-15 |
2008-12-01 |
Astellas Pharma Inc. |
Nuevos derivados de pirimidin-5-carboxamida.
|
|
US5869090A
(en)
|
1998-01-20 |
1999-02-09 |
Rosenbaum; Jerry |
Transdermal delivery of dehydroepiandrosterone
|
|
US6946144B1
(en)
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
|
ES2307482T3
(es)
|
1999-02-10 |
2008-12-01 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas.
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
DE60017898T2
(de)
|
1999-06-09 |
2006-01-12 |
Yamanouchi Pharmaceutical Co., Ltd. |
Neuartige heterocyclische carboxamidderivate
|
|
WO2000076980A1
(en)
|
1999-06-10 |
2000-12-21 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
AU5666300A
(en)
|
1999-06-25 |
2001-01-31 |
Robert S. Hodges |
Polypeptide compositions formed using a coiled-coil template and methods of use
|
|
US6465014B1
(en)
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
|
US6960563B2
(en)
|
2001-08-31 |
2005-11-01 |
Morton Grove Pharmaceuticals, Inc. |
Spontaneous emulsions containing cyclosporine
|
|
CN100558715C
(zh)
|
2002-05-23 |
2009-11-11 |
西托匹亚有限公司 |
蛋白激酶抑制剂
|
|
MXPA04012855A
(es)
|
2002-06-28 |
2005-04-19 |
Yamanouchi Pharma Co Ltd |
Derivado de diaminopirimidincarboxiamida.
|
|
EP1863766B1
(en)
|
2005-03-10 |
2015-05-20 |
Gilead Connecticut, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
CA2657260A1
(en)
|
2006-07-21 |
2008-01-24 |
Novartis Ag |
2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
|
|
US20080076800A1
(en)
|
2006-08-24 |
2008-03-27 |
Huang Kenneth H |
Benzene, Pyridine, and Pyridazine Derivatives
|
|
US20080119457A1
(en)
|
2006-08-24 |
2008-05-22 |
Serenex, Inc. |
Benzene, Pyridine, and Pyridazine Derivatives
|
|
US20100160292A1
(en)
|
2006-09-11 |
2010-06-24 |
Cgi Pharmaceuticals, Inc |
Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors
|
|
CL2008002793A1
(es)
|
2007-09-20 |
2009-09-04 |
Cgi Pharmaceuticals Inc |
Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
|
|
WO2009114470A2
(en)
|
2008-03-10 |
2009-09-17 |
Curis, Inc. |
Tetrahydroindole and tetrahdyroindazole as hsp90 inhibitors containing a zinc binding moiety
|
|
FR2928645A1
(fr)
|
2008-03-14 |
2009-09-18 |
Sanofi Aventis Sa |
Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
|
|
WO2009145856A1
(en)
|
2008-04-16 |
2009-12-03 |
Portola Pharmaceuticals, Inc. |
2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
|
|
JP5802127B2
(ja)
|
2008-04-16 |
2015-10-28 |
ポートラ ファーマシューティカルズ， インコーポレイテッド |
Ｓｙｋ又はｊａｋキナーゼ阻害剤としての２，６−ジアミノ−ピリミジン−５−イル−カルボキサミド類
|
|
AU2009238590A1
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
WO2009137596A1
(en)
|
2008-05-06 |
2009-11-12 |
Cgi Pharmaceuticals, Inc. |
Substituted amides, method of making, and use as btk inhibitors
|
|
TWI546290B
(zh)
*
|
2008-06-27 |
2016-08-21 |
賽基艾維洛米斯研究股份有限公司 |
雜芳基化合物及其用途
|
|
JPWO2010058846A1
(ja)
|
2008-11-21 |
2012-04-19 |
アステラス製薬株式会社 |
４，６−ジアミノニコチンアミド化合物
|
|
KR20100097077A
(ko)
|
2009-02-25 |
2010-09-02 |
주식회사 중외제약 |
Ｈｓｐ90에 대한 억제 효능을 갖는 피리디논 유도체
|
|
WO2010129802A1
(en)
|
2009-05-06 |
2010-11-11 |
Portola Pharmaceuticals, Inc. |
Inhibitors of jak
|
|
US8969336B2
(en)
|
2009-05-08 |
2015-03-03 |
Astellas Pharma Inc. |
Diamino heterocyclic carboxamide compound
|
|
BRPI1010882A2
(pt)
|
2009-06-08 |
2019-09-24 |
California Capital Equity Llc |
derivados de triazina e suas aplicações terapêuticas.
|
|
EP2440204B1
(en)
|
2009-06-12 |
2013-12-18 |
Bristol-Myers Squibb Company |
Nicotinamide compounds useful as kinase modulators
|
|
CN102311389A
(zh)
|
2010-06-29 |
2012-01-11 |
王小龙 |
一种氮芳香取代吡唑衍生物、及其合成和抗癌应用
|
|
BR112012033770A2
(pt)
|
2010-06-30 |
2016-11-22 |
Fujifilm Corp |
novo derivado de nicotinamida ou sal do mesmo
|
|
JP2014005206A
(ja)
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
|
WO2012061415A1
(en)
|
2010-11-01 |
2012-05-10 |
Portola Pharmaceuticals, Inc. |
Oxypyrimidines as syk modulators
|
|
EP2975027A1
(en)
|
2010-11-01 |
2016-01-20 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as jak kinase modulators
|
|
WO2012061418A2
(en)
|
2010-11-01 |
2012-05-10 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as syk modulators
|
|
WO2012100135A1
(en)
|
2011-01-21 |
2012-07-26 |
Abbott Laboratories |
Picolinamide inhibitors of kinases
|
|
SG10201702654VA
(en)
|
2011-04-22 |
2017-06-29 |
Signal Pharm Llc |
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
WO2013054351A1
(en)
|
2011-08-08 |
2013-04-18 |
Cadila Healthcare Limited |
Heterocyclic compounds
|
|
EP2762476A4
(en)
*
|
2011-09-30 |
2015-03-25 |
Taiho Pharmaceutical Co Ltd |
1,2,4-triazine-6-carboxamide derivative
|
|
CA2856306A1
(en)
|
2011-11-23 |
2013-05-30 |
Portola Pharmaceuticals, Inc. |
Selective kinase inhibitors
|
|
CN104066431B
(zh)
|
2011-11-23 |
2017-03-08 |
波托拉医药品公司 |
吡嗪激酶抑制剂
|
|
WO2013099041A1
(ja)
|
2011-12-28 |
2013-07-04 |
富士フイルム株式会社 |
新規なニコチンアミド誘導体またはその塩
|
|
TWI532727B
(zh)
*
|
2012-01-17 |
2016-05-11 |
安斯泰來製藥股份有限公司 |
吡羧醯胺化合物
|
|
US9040530B2
(en)
|
2012-06-22 |
2015-05-26 |
Portola Pharmaceuticals, Inc. |
1,2,4-triazine-6-carboxamide kinase inhibitors
|
|
US20140113931A1
(en)
|
2012-06-22 |
2014-04-24 |
Portola Pharmaceuticals, Inc. |
Substituted picolinamide kinase inhibitors
|
|
CN103664878A
(zh)
|
2012-09-12 |
2014-03-26 |
山东亨利医药科技有限责任公司 |
杂芳环及其衍生物类酪氨酸激酶抑制剂
|
|
EP2903970A4
(en)
|
2012-10-08 |
2016-11-30 |
Portola Pharm Inc |
SUBSTITUTED PYRIMIDINYL KINASE INHIBITORS
|
|
CN104870437A
(zh)
|
2013-01-17 |
2015-08-26 |
四川恒康发展有限责任公司 |
三嗪化合物、其药用盐、异构体或水合物及其药物组合物
|
|
US9145387B2
(en)
|
2013-02-08 |
2015-09-29 |
Celgene Avilomics Research, Inc. |
ERK inhibitors and uses thereof
|
|
JP2016113366A
(ja)
|
2013-03-29 |
2016-06-23 |
大鵬薬品工業株式会社 |
アセトアミド基を有する１，２，４−トリアジン−６−カルボキサミド誘導体
|
|
JP2014198693A
(ja)
*
|
2013-03-29 |
2014-10-23 |
大鵬薬品工業株式会社 |
免疫疾患の予防及び／又は治療剤
|
|
WO2015039613A1
(zh)
|
2013-09-18 |
2015-03-26 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
|
JP6345786B2
(ja)
*
|
2013-12-05 |
2018-06-20 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼの阻害剤
|